Transitions between cognitive topographies: contributions of network structure, neuromodulation, and disease.
Andrea I LuppiS Parker SingletonJustine Y HansenDanilo BzdokAmy F KuceyeskiRichard F BetzelBratislav MišićPublished in: bioRxiv : the preprint server for biology (2023)
Patterns of neural activity underlie human cognition. Transitions between these patterns are orchestrated by the brain’s network architecture. What are the mechanisms linking network structure to cognitively relevant activation patterns? Here we implement principles of network control to investigate how the architecture of the human connectome shapes transitions between 123 experimentally defined cognitive activation maps (cognitive topographies) from the NeuroSynth meta-analytic engine. We also systematically incorporate neurotransmitter receptor density maps (18 receptors and transporters) and disease-related cortical abnormality maps (11 neurodegenerative, psychiatric and neurodevelopmental diseases; N = 17 000 patients, N = 22 000 controls). Integrating large-scale multimodal neuroimaging data from functional MRI, diffusion tractography, cortical morphometry, and positron emission tomography, we simulate how anatomically-guided transitions between cognitive states can be reshaped by pharmacological or pathological perturbation. Our results provide a comprehensive look-up table charting how brain network organisation and chemoarchitecture interact to manifest different cognitive topographies. This computational framework establishes a principled foundation for systematically identifying novel ways to promote selective transitions between desired cognitive topographies.
Keyphrases
- positron emission tomography
- endothelial cells
- white matter
- computed tomography
- magnetic resonance imaging
- end stage renal disease
- electronic health record
- resting state
- mental health
- mild cognitive impairment
- ejection fraction
- contrast enhanced
- network analysis
- magnetic resonance
- machine learning
- cognitive decline
- chronic kidney disease
- patient reported outcomes
- blood brain barrier
- multiple sclerosis
- congenital heart disease
- pet ct
- brain injury
- subarachnoid hemorrhage
- induced pluripotent stem cells
- pluripotent stem cells
- binding protein
- chronic pain
- big data